By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Speedel Pharmaceuticals, Inc. 

1661 Route 22 West
P.O. Box 6532
Bridgewater  New Jersey  08807  U.S.A.
Phone: 732-537-2290 Fax: 732-537-2292


SEARCH JOBS


Industry
Pharmaceutical






Company News
Speedel Pharmaceuticals, Inc. Release: SP100(Tekturna/Rasilex) Demonstrates Potential to Prodtect Kidneys from Damage 6/5/2008 10:28:13 AM
Novartis Corporation (NVS) and Speedel Pharmaceuticals, Inc. at Loggerheads Over Tekturna Royalties 11/16/2007 12:40:40 PM
Speedel Pharmaceuticals, Inc. Release: New Data Highlights Potential of Spp100 (Tekturna) as Gold Standard Therapy in Treatment of Hypertension 5/21/2007 10:36:06 AM
Speedel Pharmaceuticals, Inc. Release: Shareholders Approve All Proposals at Annual General Meeting 5/10/2007 12:52:18 PM
Speedel Pharmaceuticals, Inc. Announces Financial Results for First Quarter 2007 5/4/2007 10:41:08 AM
Speedel Pharmaceuticals, Inc. Announces Financial Results For Full Year 2006 3/29/2007 10:30:21 AM
Speedel Stops Current SPP301 Phase III Trial In Diabetic Kidney Disease In The Interests Of Patient Safety 12/19/2006 1:35:18 PM
Speedel Pharmaceuticals, Inc. Begins Phase IIa Trial With Next Generation Renin Inhibitor 10/31/2006 5:05:31 PM
Second Major Milestone For Speedel Pharmaceuticals, Inc. In Its Goal To Develop Renin Inhibitors As Gold Standard Therapy Over The Next Decade 9/28/2006 10:52:09 AM
Abbott Laboratories (ABT) Declines Option For Speedel Pharmaceuticals, Inc. Drug 8/17/2006 8:33:02 AM
1234
//-->